Skip to main content
logo
Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.870
+0.035 (1.91%)
At close: Sep 11, 2026, 4:00 PM EDT
1.840
-0.030 (-1.60%)
After-hours: Sep 11, 2026, 7:57 PM EDT

Tvardi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2540---
Market Cap Growth
-91.90%----
Enterprise Value
94---
Last Close Price
1.874.30---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
2.091.93---
P/TBV Ratio
3.081.96---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.01-5.430.020.01
Net Debt / Equity Ratio
-1.86-1.460.19-0.96-1.07
Net Debt / EBITDA Ratio
0.581.150.041.212.05
Net Debt / FCF Ratio
0.621.300.061.072.42
Quick Ratio
1.732.793.056.9910.23
Current Ratio
1.872.863.067.9710.31
Return on Equity (ROE)
-126.18%-237.81%-329.99%-54.30%-
Return on Assets (ROA)
-55.51%-49.70%-56.48%-32.36%-
Return on Capital Employed (ROCE)
-323.70%-127.20%-113.20%-78.70%-51.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-104.49%-45.15%---
FCF Yield
-100.34%-58.25%---
Buyback Yield / Dilution
-134.87%-202.35%59.64%-0.09%-
SEC Filings: 10-K · 10-Q